Ultrasound-guided intra-tumor injection of combined immunotherapy cures mice from orthotopic prostate cancer.

about

Healthy and tumoral tissue resistivity in wild-type and sparc-/- animal models.

P2860

Q50859770-F6B1CCC2-3FE1-41FF-ADDD-2247262ED167

P2860

Ultrasound-guided intra-tumor injection of combined immunotherapy cures mice from orthotopic prostate cancer.

Item

http://www.wikidata.org/entity/Q42261548

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Ultrasound-guided intra-tumor ...... om orthotopic prostate cancer.

@en

Ultrasound-guided intra-tumor ...... om orthotopic prostate cancer.

@nl

type

Item

label

Ultrasound-guided intra-tumor ...... om orthotopic prostate cancer.

@en

Ultrasound-guided intra-tumor ...... om orthotopic prostate cancer.

@nl

prefLabel

Ultrasound-guided intra-tumor ...... om orthotopic prostate cancer.

@en

Ultrasound-guided intra-tumor ...... om orthotopic prostate cancer.

@nl

P1476

Ultrasound-guided intra-tumor ...... om orthotopic prostate cancer.

@en

P2093

Giorgio Mauri

http://www.w3.org/2001/XMLSchema#string

Ivano Arioli

http://www.w3.org/2001/XMLSchema#string

Mariella Parenza

http://www.w3.org/2001/XMLSchema#string

P2860

Chemokines: agents for the immunotherapy of cancer?

Trial watch: FDA-approved Toll-like receptor agonists for cancer therapy.

Dendritic cells infiltrating tumors cotransduced with granulocyte/macrophage colony-stimulating factor (GM-CSF) and CD40 ligand genes take up and present endogenous tumor-associated antigens, and prime naive mice for a cytotoxic T lymphocyte respons

Mechanisms of immune evasion by tumors.

Depleting tumor-specific Tregs at a single site eradicates disseminated tumors.

Adenoviral-mediated, intratumor gene transfer of interleukin 23 induces a therapeutic antitumor response

Prostate cancer, tumor immunity and a renewed sense of optimism in immunotherapy.

Paracrine cytokine adjuvants in cancer immunotherapy.

Mast cell targeting hampers prostate adenocarcinoma development but promotes the occurrence of highly malignant neuroendocrine cancers.

Intralesional injection of adenovirus encoding CC chemokine ligand 16 inhibits mammary tumor growth and prevents metastatic-induced death after surgical removal of the treated primary tumor.

P2888

s00262-013-1486-7

P304

1811-1819

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00262-013-1486-7

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Claudio Tripodo

Mario Paolo Colombo

Claudia Chiodoni

P577

2013-10-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1010424877

http://www.w3.org/2001/XMLSchema#string

P698

24136641

http://www.w3.org/2001/XMLSchema#string

P921

immunotherapy

Ultrasound-guided intra-tumor injection of combined immunotherapy cures mice from orthotopic prostate cancer.

about

P2860

P2860

Ultrasound-guided intra-tumor injection of combined immunotherapy cures mice from orthotopic prostate cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921